tiprankstipranks
Trending News
More News >
AFT Pharmaceuticals Ltd. (AU:AFP)
:AFP
Australian Market
Advertisement

AFT Pharmaceuticals Ltd. (AFP) Ratios

Compare
5 Followers

AFT Pharmaceuticals Ltd. Ratios

AU:AFP's free cash flow for Q4 2025 was $0.46. For the 2025 fiscal year, AU:AFP's free cash flow was decreased by $ and operating cash flow was $0.16. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
2.50 2.30 2.38 2.67 2.12
Quick Ratio
1.38 1.23 1.31 1.52 1.07
Cash Ratio
0.26 0.26 0.12 0.27 0.10
Solvency Ratio
0.17 0.23 0.17 0.32 0.13
Operating Cash Flow Ratio
0.30 0.63 0.29 0.49 0.02
Short-Term Operating Cash Flow Coverage
12.17 0.00 4.73 3.54 0.15
Net Current Asset Value
$ 35.60M$ 28.27M$ 19.80M$ 12.53M$ -642.00K
Leverage Ratios
Debt-to-Assets Ratio
0.18 0.19 0.26 0.32 0.40
Debt-to-Equity Ratio
0.31 0.37 0.52 0.65 1.15
Debt-to-Capital Ratio
0.24 0.27 0.34 0.39 0.54
Long-Term Debt-to-Capital Ratio
0.21 0.24 0.31 0.35 0.48
Financial Leverage Ratio
1.74 1.88 2.02 2.04 2.87
Debt Service Coverage Ratio
3.43 5.78 2.86 3.26 1.43
Interest Coverage Ratio
6.26 5.51 6.85 8.37 3.11
Debt to Market Cap
0.09 0.08 0.10 0.10 0.08
Interest Debt Per Share
0.32 0.34 0.39 0.41 0.44
Net Debt to EBITDA
1.05 0.73 1.63 1.47 3.14
Profitability Margins
Gross Profit Margin
44.09%44.78%46.59%47.40%43.09%
EBIT Margin
8.48%13.25%11.92%16.21%10.02%
EBITDA Margin
8.66%14.29%13.02%17.01%10.99%
Operating Profit Margin
8.48%10.47%12.56%15.65%9.47%
Pretax Profit Margin
7.71%11.35%10.09%14.34%6.97%
Net Profit Margin
5.75%8.04%6.80%15.23%6.88%
Continuous Operations Profit Margin
5.48%8.04%6.80%15.23%6.88%
Net Income Per EBT
74.60%70.89%67.43%106.22%98.67%
EBT Per EBIT
90.85%108.38%80.32%91.64%73.66%
Return on Assets (ROA)
7.04%9.45%7.20%15.59%7.40%
Return on Equity (ROE)
13.19%17.78%14.54%31.85%21.27%
Return on Capital Employed (ROCE)
13.94%17.05%18.16%20.75%14.66%
Return on Invested Capital (ROIC)
9.77%12.00%17.14%26.42%17.33%
Return on Tangible Assets
10.72%10.49%8.08%17.83%8.69%
Earnings Yield
4.19%4.56%2.97%5.28%1.55%
Efficiency Ratios
Receivables Turnover
4.82 4.73 3.95 4.36 3.87
Payables Turnover
4.63 4.23 3.77 5.68 4.38
Inventory Turnover
2.40 2.18 1.97 2.05 1.91
Fixed Asset Turnover
64.01 50.78 46.55 38.78 29.87
Asset Turnover
1.22 1.17 1.06 1.02 1.08
Working Capital Turnover Ratio
3.47 3.39 3.03 3.09 3.43
Cash Conversion Cycle
149.10 157.97 180.50 197.79 201.79
Days of Sales Outstanding
75.79 77.14 92.32 83.65 94.32
Days of Inventory Outstanding
152.13 167.13 184.98 178.40 190.85
Days of Payables Outstanding
78.82 86.29 96.79 64.27 83.38
Operating Cycle
227.92 244.26 277.29 262.05 285.17
Cash Flow Ratios
Operating Cash Flow Per Share
0.13 0.28 0.11 0.13 <0.01
Free Cash Flow Per Share
0.12 0.18 0.11 0.13 <0.01
CapEx Per Share
<0.01 0.09 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
0.98 0.67 0.98 0.98 0.88
Dividend Paid and CapEx Coverage Ratio
6.73 2.70 59.03 43.02 2.67
Capital Expenditure Coverage Ratio
46.89 3.03 59.03 43.02 8.06
Operating Cash Flow Coverage Ratio
0.44 0.90 0.31 0.35 0.02
Operating Cash Flow to Sales Ratio
0.06 0.15 0.07 0.11 <0.01
Free Cash Flow Yield
4.46%5.64%3.19%3.68%0.13%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
23.72 21.95 33.64 18.93 64.45
Price-to-Sales (P/S) Ratio
1.38 1.77 2.29 2.88 4.43
Price-to-Book (P/B) Ratio
2.91 3.90 4.89 6.03 13.71
Price-to-Free Cash Flow (P/FCF) Ratio
22.28 17.72 31.35 27.18 763.41
Price-to-Operating Cash Flow Ratio
21.53 11.87 30.82 26.54 668.75
Price-to-Earnings Growth (PEG) Ratio
2.37 0.44 -0.71 0.12 -1.66
Price-to-Fair Value
2.91 3.90 4.89 6.03 13.71
Enterprise Value Multiple
17.00 13.09 19.21 18.42 43.48
Enterprise Value
308.32M 362.81M 391.74M 408.23M 540.57M
EV to EBITDA
17.11 13.09 19.21 18.42 43.48
EV to Sales
1.48 1.87 2.50 3.13 4.78
EV to Free Cash Flow
23.91 18.77 34.27 29.53 822.78
EV to Operating Cash Flow
23.40 12.57 33.69 28.85 720.76
Tangible Book Value Per Share
0.38 0.68 0.54 0.44 0.20
Shareholders’ Equity Per Share
0.94 0.84 0.70 0.59 0.35
Tax and Other Ratios
Effective Tax Rate
0.29 0.29 0.33 0.06 0.01
Revenue Per Share
2.01 1.85 1.49 1.24 1.08
Net Income Per Share
0.12 0.15 0.10 0.19 0.07
Tax Burden
0.75 0.71 0.67 1.06 0.99
Interest Burden
0.91 0.86 0.85 0.88 0.70
Research & Development to Revenue
0.10 0.04 0.04 0.04 0.03
SG&A to Revenue
0.06 0.06 0.07 0.06 0.07
Stock-Based Compensation to Revenue
<0.01 <0.01 0.00 <0.01 <0.01
Income Quality
1.10 1.85 1.09 0.71 0.10
Currency in NZD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis